Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.
Celling Technologies, a subsidiary of SpineSmith Partners, is collaborating with Tissue Genesis, Inc. to research potential applications for adipose tissue derived adult stem cells. SpineSmith acquired the global rights in spine for Tissue Genesis' adipose (fat) tissue derived stem cell technology in November of 2007.
Health care companies stand to gain from legislation that would expand their market to millions of new consumers, but many are also complaining about specific provisions of the House health care overhaul bill, the New York Times reports.
Access MediQuip, LLC, the nation's first and largest provider of outsourced implantable medical device management solutions to the healthcare industry, announced today that it is relocating its corporate headquarters to Lake Mary, Florida. The move, prompted by the firm's continued rapid growth, includes a major expansion of the Primera Blvd, Lake Mary office space that will open in January 2010 and relocation and expansion of the Houston facilities to the new, LEED® certified, One & Two Oak Park complex in the Westchase District.
Progenics Pharmaceuticals, Inc. today announced its results of operations for the third quarter and nine months ended September 30, 2009.
SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the third quarter ended September 30, 2009.
Aspyra, Inc. today announced plans to demonstrate the latest release of AccessNET, the Company’s PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.
Facet Solutions, Inc. announced today that it has acquired all of the assets of Archus Orthopedics. The acquisition creates an undisputed leadership position in product offerings, intellectual property and clinical experience in posterior motion preservation. "This is a win for patients suffering from lumbar spinal stenosis," stated Facet Solutions' President & CEO, Geoff Pardo. "This consolidation further strengthens Facet Solutions' position in lumbar spine motion preservation surgery, which is the fastest growing sector of the surgical spine marketplace."
SpineSmith Partners has signed an initial agreement with GenOsteo, Inc. to co-develop a unique scaffold that mimics the structure of natural cancellous bone.
Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The nanoparticles did not cause the damage by passing through the barrier, but generated signalling molecules within the barrier cells that were then transmitted to cause damage in cells the other side of the barrier.
NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its third quarter financial results.
A study by six researchers, including a University of Colorado at Boulder associate professor and his former doctoral student, shows that amputees who use running-specific prosthetic legs have no performance advantage over counterparts who use their biological legs.
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its financial results for the third quarter of 2009.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008.
ThromboGenics NV, a biopharmaceutical company focused on innovative medicines for eye disease, vascular disease and cancer, is today issuing a business update for the period ending 30 September, 2009.
BioMimetic Therapeutics, Inc. announced today that it has received approval from Health Canada to begin the marketing of its lead orthopedic product, Augment™ Bone Graft, as an alternative to the use of autograft in midfoot, hindfoot and ankle fusion indications in Canada.
Four researchers from Thomas Jefferson University have received $3.9 million in Challenge grant funds as part of the American Recovery and Reinvestment Act.
Aggressively managing patients at risk for osteoporosis could reduce the hip fracture rate in the United States by 25 percent, according to a Kaiser Permanente study published in the November issue of the Journal of Bone & Joint Surgery. The first step must be a more active role by orthopedic surgeons in osteoporosis disease management, researchers say.
Mariner, an industry-leading business intelligence and performance management solutions provider, makes available a White Paper, entitled, “Healthcare Performance Management Strategies for Highly Efficient Practices.”
Think First announced today that the Hospital of Saint Raphael (HSR) has successfully implemented Think First’s recommendation to centralize patient scheduling and registration for their ambulatory clinics. The Hospital of Saint Raphael has worked closely with Think First consultants to execute this plan and has seen immediate results.